1. The Development and Causes of Cancer

Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell 144: 646–674.

Moore, P. S., and Y. Chang. 2010. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10: 878–889.

2. Oncogenes

Downward, J. 2006. Prelude to an anniversary for the RAS oncogene. Science 314: 433–434.

Thorpe, L. M., H. Yuzugullu, and J. J. Zhao. 2015. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat. Rev. Cancer 15: 7–24.

3. Tumor Suppressor Genes

Kastenhuber, E. R., and S. W. Lowe. 2017. Putting p53 in context. Cell 170: 1062–1078.

Vogelstein, B., N. Papadopoulos, V. E. Velculescu, S. Zhou, L. A. Diaz Jr., and K. W. Kinzler. 2013. Cancer genome landscapes. Science 339: 1546–1558.

4.  Molecular Approaches to Cancer Treatment

Fesnak, A. D., C. H. June, and B. L. Levine. 2016. Engineered T cells: the promise and challenges of cancer immunotherapy. Nat. Rev. Cancer 16: 566–581.

Haber, D. A., N. S. Gray, and J. Baselga. 2011. The evolving war on cancer. Cell 145: 19–24.

Heidi Ledford. (2018) Cancer researchers target the dormant cells that seed tumours. Nature, 558: 355-356.  （“癌症治疗新策略：靶向休眠细胞，预防复发”）